Company Filing History:
Years Active: 2019-2025
Title: Alexander Wayne Schammel: Innovator in APOL1 Inhibitors
Introduction
Alexander Wayne Schammel is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of APOL1 inhibitors. With a total of 4 patents to his name, Schammel's work is paving the way for advancements in treating APOL1-mediated diseases.
Latest Patents
Schammel's latest patents focus on APOL1 inhibitors and methods of use. These patents detail compounds of formula (II) and include various stereoisomers, tautomers, and pharmaceutically acceptable salts. The patents also outline methods for preparing these compounds and strategies for inhibiting APOL1, which could be crucial in treating related diseases, disorders, or conditions in individuals.
Career Highlights
Throughout his career, Schammel has worked with several innovative companies, including Sirenas LLC and Maze Therapeutics, Inc. His experience in these organizations has allowed him to collaborate with other talented professionals and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Some of Schammel's notable coworkers include Ippei Usui and Jacob Neal Beverage. Their collaborative efforts have further enhanced the research and development of APOL1 inhibitors.
Conclusion
Alexander Wayne Schammel is a prominent figure in the field of pharmaceutical innovation, particularly in the area of APOL1 inhibitors. His contributions and collaborations continue to influence advancements in medical treatments.